导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -15.68% | 928/1050 |
| 近一周 | -3.02% | 788/1104 |
| 近一月 | -3.71% | 446/1102 |
| 近一季 | -8.32% | 594/1092 |
| 近半年 | -14.40% | 876/1070 |
| 近一年 | -5.81% | 664/1018 |
| 近两年 | 47.20% | 520/926 |
| 近三年 | 32.22% | 374/834 |
| 成立以来 | 343.00% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.32% 920/1070 |
-6.62% 836/1101 |
- - |
- - |
| 2025 | 41.15% 306/1065 |
-1.63% 887/1014 |
-1.91% 837/1038 |
40.99% 179/1050 |
3.76% 204/1065 |
| 2024 | 19.91% 92/1011 |
3.09% 164/960 |
-1.75% 423/983 |
19.70% 70/991 |
-1.09% 387/1011 |
| 2023 | -13.62% 460/952 |
-1.59% 690/880 |
-2.08% 307/895 |
-4.35% 257/915 |
-6.28% 619/952 |
| 2022 | -18.41% 271/867 |
-15.04% 265/773 |
2.50% 649/806 |
-14.01% 514/845 |
8.96% 99/867 |
| 2021 | 20.41% 154/740 |
-5.78% 377/580 |
12.17% 307/659 |
6.32% 100/704 |
7.16% 141/740 |
| 2020 | 88.84% 62/554 |
1.21% 130/419 |
26.70% 167/466 |
16.13% 126/517 |
26.81% 53/554 |
| 2019 | 54.81% 113/410 |
29.41% 406/1149 |
-6.42% 811/1231 |
9.95% 111/390 |
16.27% 34/410 |
| 2018 | -25.21% 148/349 |
- - |
- - |
- - |
-12.29% 627/1080 |
| 2017 | 12.40% 122/285 |
- - |
- - |
- - |
- - |
| 2016 | -19.01% 113/205 |
- - |
- - |
- - |
- - |
| 2015 | 39.33% 38/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 工银研究精选股票 VS. 东吴新产业精选股票A(580008) |